Paffoni Alessio, Brevini Tiziana A L, Somigliana Edgardo, Restelli Liliana, Gandolfi Fulvio, Ragni Guido
Department of Obstetrics, Gynecology, and Neonatology, Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Milan, Italy.
Fertil Steril. 2007 Jan;87(1):77-82. doi: 10.1016/j.fertnstert.2006.05.063. Epub 2006 Oct 30.
To compare directly in vitro developmental competence between parthenogenetically activated and intracytoplasmic sperm injection (ICSI)-fertilized oocytes.
For each patient, three metaphase II oocytes were randomized to the ICSI procedure, while n-3 were allocated to parthenogenetic activation.
University hospital infertility unit.
Thirty-eight patients, aged 35.2 +/- 3.3 years (mean +/- SD) selected for ICSI.
After 1 hour from denudation, oocytes were either fertilized by ICSI (n = 114) or chemically activated (n = 104). Fertilized and activated oocytes were cultured for up to 3 and 5 days, respectively.
Development rate, cell number, and morphological grade during culture.
The two groups showed no significant differences between rates of fertilization and parthenogenetic activation, development, and blastomere number on days 2 and 3 of culture. However, parthenotes showed a lower morphological grade, and a significantly lower proportion went on cleaving to day 3, when only activated rather than total numbers of oocytes were considered. On day 5 after activation, nine oocytes (8.6%) reached the blastocyst stage, representing 12.9% of parthenotes.
Since most parameters examined in this study were similar between activated and fertilized oocytes, parthenogenetic activation may be a useful tool for the preclinical evaluation of experimental procedures.
直接比较孤雌激活卵母细胞与卵胞浆内单精子注射(ICSI)受精卵母细胞的体外发育能力。
对于每位患者,将三个中期II卵母细胞随机分配至ICSI操作组,而n - 3个卵母细胞分配至孤雌激活组。
大学医院不孕不育科。
38例患者,年龄35.2±3.3岁(均值±标准差),入选接受ICSI治疗。
去卵丘1小时后,卵母细胞分别通过ICSI受精(n = 114)或化学激活(n = 104)。受精和激活的卵母细胞分别培养长达3天和5天。
培养期间的发育率、细胞数量和形态学分级。
两组在受精率与孤雌激活率、培养第2天和第3天的发育率和卵裂球数量方面无显著差异。然而,孤雌激活胚胎形态学分级较低,当仅考虑激活而非全部卵母细胞数量时,发育至第3天的比例显著较低。激活后第5天,9个卵母细胞(8.6%)发育至囊胚期,占孤雌激活胚胎的12.9%。
由于本研究中检测的大多数参数在激活卵母细胞和受精卵母细胞之间相似,孤雌激活可能是实验操作临床前评估的有用工具。